Chemoinformaics analysis of 11beta,13-Dihydrourospermal A
| Molecular Weight | 431.573 | nRot | 4 |
| Heavy Atom Molecular Weight | 394.277 | nRig | 1 |
| Exact Molecular Weight | 431.267 | nRing | 6 |
| Solubility: LogS | -4.728 | nHRing | 1 |
| Solubility: LogP | 4.584 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 7 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 37 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 71.5313 |
| nHD | 1 | BPOL | 44.9047 |
| QED | 0.415 |
| Synth | 2.292 |
| Natural Product Likeliness | 0.753 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.852 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.402 |
| MDCK | 0.0000115 |
| BBB | 0.898 |
| PPB | 0.968052 |
| VDSS | 2.067 |
| FU | 0.0060635 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.538 |
| CYP2c19-inh | 0.886 |
| CYP2c19-sub | 0.698 |
| CYP2c9-inh | 0.692 |
| CYP2c9-sub | 0.949 |
| CYP2d6-inh | 0.323 |
| CYP2d6-sub | 0.136 |
| CYP3a4-inh | 0.447 |
| CYP3a4-sub | 0.125 |
| CL | 7.96 |
| T12 | 0.382 |
| hERG | 0.055 |
| Ames | 0.007 |
| ROA | 0.042 |
| SkinSen | 0.927 |
| Carcinogencity | 0.117 |
| EI | 0.97 |
| Respiratory | 0.359 |
| NR-Aromatase | 0.024 |
| Antiviral | Yes |
| Prediction | 0.827234 |